Aarey Drugs And Pharmaceuticals Limited - Company Profile

It is a chemicals and materials public limited company based in Thane, Maharashtra, India, established in 1990.
1990 Thane, Maharashtra, India Active
Last Updated:
About Aarey Drugs And Pharmaceuticals Limited

Aarey Drugs And Pharmaceuticals Limited, a active public limited company, was established on 15 May 1990 in Thane, Maharashtra, India. Engaging in specialty chemicals within the manufacturing sector, it holds CIN: L99999MH1990PLC056538. Registered under ROC Roc Mumbai. it is listed on BSE: 524412 and NSE: AAREYDRUGS. It has an authorized capital of ₹35.50 Cr and a paid-up capital of ₹28.35 Cr.

Formerly known as Niharika Textiles And Chemicals Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹402.58 Cr and a net worth of ₹132.76 Cr. Its leadership includes Chetan Kiritbhai Mehta (Director), Bina Rajesh Ghatalia (Director), Mihir Rajesh Ghatalia (Managing Director). Past directors included Bina Rajesh Ghatalia, Rajesh P Ghatalia, Damayantiben Pranlal Ghatalia. It holds ₹64.44 Cr open charges and ₹38.84 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at E-34, M.I.D.C., Tarapur, Boisar,, Thane, Maharashtra, 401506.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    L99999MH1990PLC056538

  • Registration Number

    056538

  • Incorporation Date

    15 May 1990

  • Authorized Capital

    ₹35.50 Cr

  • Paid-Up Capital

    ₹28.35 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Listed (BSE: 524412, NSE: AAREYDRUGS)

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 35.50 Cr
  • Paid Up Capital ₹ 28.35 Cr
  • Company Age 35 Year, 9 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 64.44 Cr
  • Satisfied Charges ₹ 38.84 Cr
  • Revenue Growth **** -4.53%
  • Profit Growth **** 24.20%
  • Ebitda **** -16.06%
  • Net Worth 13.07%
  • Total Assets **** 4.11%
Company report

Aarey Drugs And Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Aarey Drugs And Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Aarey Drugs And Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Chetan Kiritbhai Mehta Director 02 Jun 2008 Current
Bina Rajesh Ghatalia Director 09 Oct 2023 Current
Mihir Rajesh Ghatalia Managing Director 02 Aug 2004 Current
Lalit Radhakrishna Tulsiani Director 29 Jan 2020 Current
Anil Mandal Director 01 Jul 2020 Current
Nimit Rajesh Ghatalia Director 01 Jul 2020 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 28 Dec 2023 Past
Pramod Abcsdd Cfo(Kmp) - Past
Pramod Abcsdd Director 24 Jan 2020 Past
Pramod Abcsdd Cfo(Kmp) 22 Jul 2015 Past
Pramod Abcsdd Managing Director 08 Feb 2018 Past
Pramod Abcsdd Director 02 Jun 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aarey Drugs And Pharmaceuticals.

Aarey Drugs And Pharmaceuticals Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 4.53% decrease. The company also saw a substantial improvement in profitability, with a 24.2% increase in profit. The company's net worth Soared by an impressive increase of 13.07%.

Aarey Drugs And Pharmaceuticals revenue growth over time
Aarey Drugs And Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
-4.53%
*******
*******
*******
*******
Revenue from Operations
*******
-5.09%
*******
*******
*******
*******
Total Assets
*******
4.11%
*******
*******
*******
*******
Profit or Loss
*******
24.20%
*******
*******
*******
*******
Net Worth
*******
13.07%
*******
*******
*******
*******
EBITDA
*******
-16.06%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aarey Drugs And Pharmaceuticals?

In 2023, Aarey Drugs And Pharmaceuticals had a promoter holding of 50.05% and a public holding of 49.95%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹644,400,000.00

Satisfied Charges

₹388,360,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 64.44 Cr
Latest Charge Details
Date Lender Amount Status
23 Jan 2023 State Bank Of India ₹64.44 Cr Open
19 Dec 2022 Others ₹1.67 Cr Satisfied
12 Sep 2022 Others ₹4.00 Cr Satisfied
07 Sep 2021 Others ₹3.34 Cr Satisfied
23 Apr 2020 Others ₹1.95 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Aarey Drugs And Pharmaceuticals?

Unlock and access historical data on people associated with Aarey Drugs And Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Aarey Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarey Drugs And Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aarey Drugs And Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Aarey Drugs And Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.

  • Director Appointment

    Kailash Chand Jethlia was appointed as a Company Secretary was appointed as a Company Secretary on 02 Apr 2025 & has been associated with this company since 11 months 3 days . was recorded as a recent event.

  • Balance Sheet

    Progress on Aarey Drugs And Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Charges

    The activity A charge with State Bank Of India of Rs. 64.44 Cr registered on 23 Jan 2023 with Charge ID 100675561 was modified on 15 May 2024. was completed.

  • Charges

    The activity A charge registered on 28 Jul 2014 via Charge ID 10516189 with Dena Bank was fully satisfied on 29 Apr 2024. was completed.

  • Charges

    A charge registered on 19 Dec 2022 via Charge ID 100656597 with Others was fully satisfied on 15 Apr 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Aarey Drugs And Pharmaceuticals Limited?

The CIN of Aarey Drugs And Pharmaceuticals Limited is L99999MH1990PLC056538.

Where is Aarey Drugs And Pharmaceuticals Limited headquartered?

Aarey Drugs And Pharmaceuticals Limited is headquartered at E-34, M.I.D.C., Tarapur, Boisar,, Thane, Maharashtra, 401506.

When was Aarey Drugs And Pharmaceuticals Limited incorporated?

Aarey Drugs And Pharmaceuticals Limited was incorporated on 15 May 1990.

Who are the current directors of Aarey Drugs And Pharmaceuticals Limited?

The current directors of Aarey Drugs And Pharmaceuticals Limited are

What is the primary industry of Aarey Drugs And Pharmaceuticals Limited?

The primary industry of Aarey Drugs And Pharmaceuticals Limited is Manufacturing.

Is Aarey Drugs And Pharmaceuticals Limited a listed company?

Aarey Drugs And Pharmaceuticals Limited is listed. It is listed on BSE: 524412 and NSE: AAREYDRUGS.

What is the capital structure of Aarey Drugs And Pharmaceuticals Limited?

The authorized capital of Aarey Drugs And Pharmaceuticals Limited is ₹35.50 Cr, and the paid-up capital is ₹28.35 Cr.

What is the compliance status of Aarey Drugs And Pharmaceuticals Limited?

The compliance status of Aarey Drugs And Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available